Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
AbstractKawasaki disease (KD) is an autoimmune-like disease and acute childhood vasculitis syndrome that affects various systems but has unknown etiology. In addition to the standard diagnostic criteria, anemia is among the most common clinical features of KD patients and is thought to have a more prolonged duration of active inflammation. In 2001, the discovery of a liver-derived peptide hormone known as hepcidin began revolutionizing our understanding of anemia’s relation to a number of inflammatory diseases, including KD. This review focuses on hepcidin-induced iron deficiency’s relation to transient hyposideremia, anemia, and disease outcomes in KD patients, and goes on to suggest possible routes of further study. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Huang, Y.-H.; Kuo, H.-C. Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. Int. J. Mol. Sci. 2017, 18, 820.
Huang Y-H, Kuo H-C. Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. International Journal of Molecular Sciences. 2017; 18(4):820.Chicago/Turabian Style
Huang, Ying-Hsien; Kuo, Ho-Chang. 2017. "Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker." Int. J. Mol. Sci. 18, no. 4: 820.